Journal Mobile Options
Table of Contents
Vol. 4, No. 4, 2011
Issue release date: November 2011
J Nutrigenet Nutrigenomics 2011;4:192–202

Effects of a Supplementation of n-3 Polyunsaturated Fatty Acids with or without Fish Gelatin on Gene Expression in Peripheral Blood Mononuclear Cells in Obese, Insulin-Resistant Subjects

Rudkowska I. · Ponton A. · Jacques H. · Lavigne C. · Holub B.J. · Marette A. · Vohl M.-C.
aInstitute of Nutraceuticals and Functional Foods (INAF), Laval University, Quebec, Qué., bMcGill University and Génome Québec Innovation Centre, Montreal, Qué., cDepartment of Food Science and Nutrition, and dQuebec Heart and Lung Institute Research Centre, Laval University, Quebec, Qué., eDepartment of Human Health and Nutritional Sciences, University of Guelph, Guelph, Ont., and fLaboratory of Endocrinology and Genomics, Laval University Hospital Research Center, Quebec, Qué., Canada

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


Aim: To investigate gene expression changes in peripheral blood mononuclear cells (PBMCs) following an n-3 polyunsaturated fatty acid (PUFA) and n-3 PUFA plus fish gelatin (+FG) supplementation. Methods: A transcriptome comparison of 8-week supplementation with n-3 PUFA and n-3 PUFA+FG was carried out in PBMCs of 16 obese insulin-resistant subjects. Results: Erythrocyte n-3 PUFA concentration increased and plasma triglycerides decreased significantly without altering inflammatory parameters after both supplementations. n-3 PUFA supplementation changed the expression of 805 genes, whereas n-3 PUFA+FG supplementation altered the expression of 184 genes. Three genes were commonly changed: fatty acid desaturase 1, free fatty acid receptor 3, and ectodysplasin. Pathway analyses indicate changes in gene expression via the nuclear receptor peroxisome proliferator-activated receptor α pathway after both supplementations. Further, the extent of modifications in the expression of genes implicated in the inflammatory pathways – the oxidative stress response mediated by nuclear factor (erythroid-derived 2)-like 2, nuclear transcription factor ĸB, oxidative stress, and hypoxia-inducible factor signaling – was different after each supplementation. Conclusion: Although n-3 PUFA and n-3 PUFA+FG supplementations have a distinct impact on gene expression levels, the consequences on biochemical parameters and metabolic pathways were comparable after both supplementations.

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Rudkowska I: Fish oils for cardiovascular disease: impact on diabetes. Maturitas 2010;67:25–28.
  2. Lavigne C, Marette A, Jacques H: Cod and soy proteins compared with casein improve glucose tolerance and insulin sensitivity in rats. Am J Physiol Endocrinol Metab 2000;278:E491–E500.
  3. Lavigne C, Tremblay F, Asselin G, Jacques H, Marette A: Prevention of skeletal muscle insulin resistance by dietary cod protein in high fat-fed rats. Am J Physiol Endocrinol Metab 2001;281:E62–E71.
  4. Ait-Yahia D, Madani S, Savelli JL, Prost J, Bouchenak M, Belleville J: Dietary fish protein lowers blood pressure and alters tissue polyunsaturated fatty acid composition in spontaneously hypertensive rats. Nutrition 2003;19:342–346.
  5. Ait Yahia D, Madani S, Prost J, Bouchenak M, Belleville J: Fish protein improves blood pressure but alters HDL2 and HDL3 composition and tissue lipoprotein lipase activities in spontaneously hypertensive rats. Eur J Nutr 2005;44:10–17.
  6. Beauchesne-Rondeau E, Gascon A, Bergeron J, Jacques H: Plasma lipids and lipoproteins in hypercholesterolemic men fed a lipid-lowering diet containing lean beef, lean fish, or poultry. Am J Clin Nutr 2003;77:587–593.
  7. Bergeron N, Jacques H: Influence of fish protein as compared to casein and soy protein on serum and liver lipids, and serum lipoprotein cholesterol levels in the rabbit. Atherosclerosis 1989;78:113–121.
  8. Bergeron N, Deshaies Y, Lavigne C, Jacques H: Interaction between dietary proteins and lipids in the regulation of serum and liver lipids in the rabbit. Effect of fish protein. Lipids 1991;26:759–764.
  9. Bergeron N, Deshaies Y, Jacques H: Dietary fish protein modulates high density lipoprotein cholesterol and lipoprotein lipase activity in rabbits. J Nutr 1992;122:1731–1737.
  10. Boukortt FO, Girard A, Prost JL, Ait-Yahia D, Bouchenak M, Belleville J: Fish protein improves the total antioxidant status of streptozotocin-induced diabetes in spontaneously hypertensive rat. Med Sci Monit 2004;10:BR397–BR404.
  11. Demonty I, Deshaies Y, Jacques H: Dietary proteins modulate the effects of fish oil on triglyceridemia in the rat. Lipids 1998;33:913–921.
  12. Demonty I, Deshaies Y, Lamarche B, Jacques H: Cod protein lowers the hepatic triglyceride secretion rate in rats. J Nutr 2003;133:1398–1402.
  13. Liew CC, Ma J, Tang HC, Zheng R, Dempsey AA: The peripheral blood transcriptome dynamically reflects system wide biology: a potential diagnostic tool. J Lab Clin Med 2006;147:126–132.
  14. Kussmann M, Raymond F, Affolter M: OMICS-driven biomarker discovery in nutrition and health. J Biotechnol 2006;124:758–787.
  15. Bouwens M, van de RO, Dellschaft N, et al: Fish-oil supplementation induces antiinflammatory gene expression profiles in human blood mononuclear cells. Am J Clin Nutr 2009;90:415–424.
  16. Rudkowska I, Marcotte B, Pilon G, Lavigne C, Marette A, Vohl MC: Fish nutrients decrease expression levels of tumor necrosis factor-α in cultured human macrophages. Physiol Genomics 2010;40:189–194.
  17. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486–2497.
  18. Folch FJ, Lees M, Sloane Stanley GH: A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 1957;226:497–509.
  19. Stark KD, Holub BJ: Differential eicosapentaenoic acid elevations and altered cardiovascular disease risk factor responses after supplementation with docosahexaenoic acid in postmenopausal women receiving and not receiving hormone replacement therapy. Am J Clin Nutr 2004;79:765–773.
  20. Blazejczyk M, Miron M, Nadon R: FlexArray: A Statistical Data Analysis Software for Gene Expression Microarrays. Genome Quebec, Montreal, 2007.
  21. Bolstad BM, Irizarry RA, Astrand M, Speed TP: A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 2003;19:185–193.
  22. Tusher VG, Tibshirani R, Chu G: Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 2001;98:5116–5121.
  23. American Diabetes Association: Diagnosis and classification of diabetes mellitus. Diabetes Care 2006;29(suppl 1):S43–S48.
  24. Lattka E, Illig T, Heinrich J, Koletzko B: FADS gene cluster polymorphisms: important modulators of fatty acid levels and their impact on atopic diseases. J Nutrigenet Nutrigenomics 2009;2:119–128.
  25. Ichimura A, Hirasawa A, Hara T, Tsujimoto G: Free fatty acid receptors act as nutrient sensors to regulate energy homeostasis. Prostaglandins Other Lipid Mediat 2009;89:82–88.
  26. Israelian-Konaraki Z, Reaven PD: Peroxisome proliferator-activated receptor-α and atherosclerosis: from basic mechanisms to clinical implications. Cardiol Rev 2005;13:240–246.
  27. Bouwens M, Afman LA, Muller M: Activation of peroxisome proliferator-activated receptor α in human peripheral blood mononuclear cells reveals an individual gene expression profile response. BMC Genomics 2008;9:262.
  28. Sluimer JC, Daemen MJ: Novel concepts in atherogenesis: angiogenesis and hypoxia in atherosclerosis. J Pathol 2009;218:7–29.

    External Resources

  29. Villaret A, Galitzky J, Decaunes P, et al: Adipose tissue endothelial cells from obese human subjects: differences among depots in angiogenic, metabolic, and inflammatory gene expression and cellular senescence. Diabetes 2010;59:2755–2763.
  30. Chapkin RS, Kim W, Lupton JR, McMurray DN: Dietary docosahexaenoic and eicosapentaenoic acid: emerging mediators of inflammation. Prostaglandins Leukot Essent Fatty Acids 2009;81:187–191.
  31. Bai SK, Lee SJ, Na HJ, et al: β-Carotene inhibits inflammatory gene expression in lipopolysaccharide-stimulated macrophages by suppressing redox-based NF-ĸB activation. Exp Mol Med 2005;37:323–334.
  32. Crespo I, Garcia-Mediavilla MV, Gutierrez B, Sanchez-Campos S, Tunon MJ, Gonzalez-Gallego J: A comparison of the effects of kaempferol and quercetin on cytokine-induced pro-inflammatory status of cultured human endothelial cells. Br J Nutr 2008;100:968–976.
  33. Hermsdorff HH, Zulet MA, Puchau B, Martinez JA: Fruit and vegetable consumption and proinflammatory gene expression from peripheral blood mononuclear cells in young adults: a translational study. Nutr Metab (Lond) 2010;7:42.

    External Resources

  34. Maritim AC, Sanders RA, Watkins JB 3rd: Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol 2003;17:24–38.
  35. Li J, Ichikawa T, Janicki JS, Cui T: Targeting the Nrf2 pathway against cardiovascular disease. Expert Opin Ther Targets 2009;13:785–794.
  36. Gao L, Wang J, Sekhar KR, Yin H, Yared NF, Schneider SN, Sasi S, Dalton TP, Anderson ME, Chan JY, Morrow JD, Freeman ML: Novel n-3 fatty acid oxidation products activate Nrf2 by destabilizing the association between Keap1 and Cullin3. J Biol Chem 2007;282:2529–2537.
  37. Mann GE, Bonacasa B, Ishii T, Siow RC: Targeting the redox sensitive Nrf2-Keap1 defense pathway in cardiovascular disease: protection afforded by dietary isoflavones. Curr Opin Pharmacol 2009;9:139–145.

Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50